FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and represents a prolonged-release pharmaceutical composition containing entacapone, consisting of an immediate-release layer and a prolonged-release layer.
EFFECT: composition provides the prolonged release of the therapeutic agent, its uniform blood plasma concentration and lower rate of composition intake.
11 cl, 11 ex, 23 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF | 2009 |
|
RU2519159C2 |
| PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE, LEVODOPA AND CARBIDOPA WITH IMPROVED BIOAVAILABILITY | 2009 |
|
RU2485947C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF LEVODOPA PRODRUG AND METHODS OF USING | 2010 |
|
RU2537137C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
| COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2318497C2 |
| METHODS FOR PREPARING ERGOT ALKALOIDS PHARMACEUTICAL COMPOSITIONS WITH PROLONGED EFFECT CHARACTERIZING WITH IMPROVED BIOAVAILABILITY AND COMPOSITIONS COMPRISING INDICATED ALKALOIDS | 2000 |
|
RU2256454C2 |
